1. Home
  2. MDAI vs LUNG Comparison

MDAI vs LUNG Comparison

Compare MDAI & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spectral AI Inc.

MDAI

Spectral AI Inc.

HOLD

Current Price

$1.67

Market Cap

53.8M

Sector

Health Care

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.35

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDAI
LUNG
Founded
2013
1995
Country
United States
United States
Employees
65
N/A
Industry
Medical/Dental Instruments
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.8M
57.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MDAI
LUNG
Price
$1.67
$1.35
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$3.00
$5.38
AVG Volume (30 Days)
260.4K
557.6K
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.64
EPS
N/A
N/A
Revenue
N/A
$90,497,000.00
Revenue This Year
N/A
$2.48
Revenue Next Year
$23.50
$18.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.01
52 Week Low
$1.18
$1.13
52 Week High
$2.97
$3.88

Technical Indicators

Market Signals
Indicator
MDAI
LUNG
Relative Strength Index (RSI) 39.57 45.79
Support Level $1.62 $1.22
Resistance Level $1.77 $1.65
Average True Range (ATR) 0.08 0.12
MACD 0.00 -0.00
Stochastic Oscillator 17.61 34.67

Price Performance

Historical Comparison
MDAI
LUNG

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: